492 related articles for article (PubMed ID: 32255127)
61. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
[TBL] [Abstract][Full Text] [Related]
62. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
63. Ce6/Mn
Gao Y; Zhang L; Liu Y; Sun S; Yin Z; Zhang L; Li A; Lu G; Wu A; Zeng L
Nanoscale; 2020 Jan; 12(3):1801-1810. PubMed ID: 31898712
[TBL] [Abstract][Full Text] [Related]
64. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy.
Zhang R; Wan Y; Lv H; Li F; Lee CS
J Mater Chem B; 2021 Sep; 9(36):7544-7556. PubMed ID: 34551052
[TBL] [Abstract][Full Text] [Related]
65. Tumor-Targeted Polydopamine-Based Nanoparticles for Multimodal Mapping Following Photothermal Therapy of Metastatic Lymph Nodes.
Liang Y; Guo W; Li C; Shen G; Tan H; Sun P; Chen Z; Huang H; Li Z; Li Z; Ren Y; Li G; Hu Y
Int J Nanomedicine; 2022; 17():4659-4675. PubMed ID: 36199474
[TBL] [Abstract][Full Text] [Related]
66. Reversing Immune Suppression and Potentiating Photothermal Immunotherapy via Bispecific Immune Checkpoint Inhibitor Loaded Hollow Polydopamine Nanospheres.
Guo K; Chen D; Ren S; Younis MR; Teng Z; Zhang L; Wang Z; Tian Y
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36881613
[TBL] [Abstract][Full Text] [Related]
67. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
Moon Y; Shim MK; Choi J; Yang S; Kim J; Yun WS; Cho H; Park JY; Kim Y; Seong JK; Kim K
Theranostics; 2022; 12(5):1999-2014. PubMed ID: 35265195
[No Abstract] [Full Text] [Related]
68. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.
Taki S; Matsuoka K; Nishinaga Y; Takahashi K; Yasui H; Koike C; Shimizu M; Sato M; Sato K
J Immunother Cancer; 2021 Oct; 9(11):. PubMed ID: 34725216
[TBL] [Abstract][Full Text] [Related]
69. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
[TBL] [Abstract][Full Text] [Related]
70. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
71. One-pot synthesis of hollow PDA@DOX nanoparticles for ultrasound imaging and chemo-thermal therapy in breast cancer.
Zhang T; Jiang Z; Xve T; Sun S; Li J; Ren W; Wu A; Huang P
Nanoscale; 2019 Nov; 11(45):21759-21766. PubMed ID: 31482919
[TBL] [Abstract][Full Text] [Related]
72. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors.
Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J
ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768
[TBL] [Abstract][Full Text] [Related]
73. Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases.
Mu X; Zhang M; Wei A; Yin F; Wang Y; Hu K; Jiang J
Nanoscale; 2021 May; 13(19):8998-9008. PubMed ID: 33973580
[TBL] [Abstract][Full Text] [Related]
74. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.
He C; Duan X; Guo N; Chan C; Poon C; Weichselbaum RR; Lin W
Nat Commun; 2016 Aug; 7():12499. PubMed ID: 27530650
[TBL] [Abstract][Full Text] [Related]
75. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
76. PolyTLR7/8a-conjugated, antigen-trapping gold nanorods elicit anticancer immunity against abscopal tumors by photothermal therapy-induced in situ vaccination.
Liu X; Su Q; Song H; Shi X; Zhang Y; Zhang C; Huang P; Dong A; Kong D; Wang W
Biomaterials; 2021 Aug; 275():120921. PubMed ID: 34139508
[TBL] [Abstract][Full Text] [Related]
77. Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging.
Li Z; Hu Y; Howard KA; Jiang T; Fan X; Miao Z; Sun Y; Besenbacher F; Yu M
ACS Nano; 2016 Jan; 10(1):984-97. PubMed ID: 26655250
[TBL] [Abstract][Full Text] [Related]
78. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
[TBL] [Abstract][Full Text] [Related]
79. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat.
Nkanga CI; Ortega-Rivera OA; Steinmetz NF
Nanomedicine; 2022 Aug; 44():102573. PubMed ID: 35728739
[TBL] [Abstract][Full Text] [Related]
80. Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy.
Guan X; Lin L; Chen J; Hu Y; Sun P; Tian H; Maruyama A; Chen X
J Control Release; 2019 Jan; 293():104-112. PubMed ID: 30476528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
